Thursday, March 19, 2015 Daily Archives

Three Steps to Start You on the Path to Obtaining the Best Recombinant CHO Cell Line

by

When developing efficient, high quality biomanufacturing processes, it is imperative that the expression system (‘host cell line’ and ‘vector’) and the process to isolate and identify the best clonal cell line (‘clonal cell line development process’) are of the highest quality. At FUJIFILM Diosynth Biotechnologies a team of scientists has invested more than 20 FTE years undertaking innovation work which has culminated in the development of a new host cell line and vector, along with an optimised clonal cell line…

March 19, 2015

Novasep Selected for Commercial Biomanufacturing of Celladon’s Mydicar API

by

Novasep, a leading supplier of services and technologies for the life sciences industry, today announces that it has entered into an agreement with Celladon, a clinical-stage biotechnology company, to prepare the supply of the drug substance for MYDICAR®. The €4.7M deal covers scale-up and pre-validation studies as well as facility enhancement engineering Novasep will make at its Seneffe (Belgium) bioproduction plant to enable it to bring advanced heart failure drug MYDICAR into commercial production. In addition, Novasep and Celladon have…

March 19, 2015

Queen Mary University of London Wins 2014 Terumo BCT Plasma Exchange Innovation Award

by

Terumo BCT is pleased to announce that Queen Mary University of London (QMUL) has been named the recipient of the 2014 Plasma Exchange Innovation Award. The award is part of a program that supports one or more grants up to $100,000 to fund innovative science and research that will generate novel therapeutic plasma exchange practices. The lead investigator is Rino Cerio, BSc, MBBS, FRCP (Edin.), FRCP (Lon.) FRCPath. He is Professor of Dermatopathology and senior consultant dermatologist at QMUL and…

March 19, 2015